Replies to post #118854 on Biotech Values

[jbog]

Dew,

I'm surprise that Emerck (rebif and cladribine) basically emerged from the whole MS scene without any damage. Actually I think they hit a year old high today.

I think they are talking to the FDA about cladribine this week.